Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners and animal health clinics. The Company provides its services to dental practitioners and laboratories, animal health clinics and physician practices, as well as government and institutional healthcare clinics.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Equipment Wholesale
- Sub-Industry: Health Care Distributors
- Symbol: NASDAQ:HSIC
- CUSIP: 80640710
- Web: www.henryschein.com
Capitalization:- Market Cap: $13.4 billion
- Outstanding Shares: 79,055,000
Average Prices:- 50 Day Moving Avg: $179.49
- 200 Day Moving Avg: $175.49
- 52 Week Range: $146.23 - $186.99
P/E:- Trailing P/E Ratio: 24.77
- Foreward P/E Ratio: 21.13
- P/E Growth: 2.34
Sales & Book Value:- Annual Revenue: $11.97 billion
- Price / Sales: 1.12
- Book Value: $36.95 per share
- Price / Book: 4.59
Profitability:- EBIDTA: $1.02 billion
- Net Margins: 4.59%
- Return on Equity: 19.91%
- Return on Assets: 8.34%
Debt:- Debt-to-Equity Ratio: 0.28%
- Current Ratio: 1.55%
- Quick Ratio: 0.85%
Misc:- Average Volume: 396,948 shs.
- Beta: 1.09
- Short Ratio: 5.11
Frequently Asked Questions for Henry Schein (NASDAQ:HSIC)
What is Henry Schein's stock symbol?
Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."
When did Henry Schein's stock split? How did Henry Schein's stock split work?
Henry Schein's stock split on the morning of Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly issued shares will be issued to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.
How were Henry Schein's earnings last quarter?
Henry Schein, Inc. (NASDAQ:HSIC) issued its earnings results on Tuesday, August, 8th. The company reported $1.75 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.73 by $0.02. The company earned $3.06 billion during the quarter, compared to the consensus estimate of $3.05 billion. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. Henry Schein's revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.64 EPS. View Henry Schein's Earnings History.
What guidance has Henry Schein issued on next quarter's earnings?
Henry Schein issued an update on its FY17 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of $7.17-7.30 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.29.
Where is Henry Schein's stock going? Where will Henry Schein's stock price be in 2017?
15 brokerages have issued 12 month price targets for Henry Schein's shares. Their predictions range from $160.00 to $218.00. On average, they anticipate Henry Schein's share price to reach $184.07 in the next twelve months. View Analyst Ratings for Henry Schein.
Who are some of Henry Schein's key competitors?
Some companies that are related to Henry Schein include Astellas Pharma (ALPMY), Incyte Corporation (INCY), Edwards Lifesciences Corporation (EW), C.R. Bard (BCR), Zimmer Biomet Holdings (ZBH), Cerner Corporation (CERN), Cardinal Health (CAH), Quintiles Transitional Holdings (Q), Lonza Group Ag (LZAGY), Teva Pharmaceutical Industries Limited (TEVA), AmerisourceBergen Corporation (Holding Co) (ABC), Mylan N.V. (MYL), Laboratory Corporation of America Holdings (LH), Smith & Nephew SNATS (SNN), Eisai Co., Ltd (ESALY), Centene Corporation (CNC), Quest Diagnostics Incorporated (DGX) and BioMarin Pharmaceutical (BMRN).
Who are Henry Schein's key executives?
Henry Schein's management team includes the folowing people:
- Stanley M. Bergman, Chairman of the Board, Chief Executive Officer
- James P. Breslawski CPA, President, Director; Chief Executive Officer of Henry Schein Global Dental Group
- Steven Paladino CPA, Chief Financial Officer, Executive Vice President, Director
- Peter McCarthy, President of Global Animal Health Group
- David C. McKinley, President of Corporate Commercial Development Group, Chief Commercial Officer
- Bob Minowitz, President, International Dental Group, EMEA Region
- Bridget A. Ross, President of Global Medical Group
- Gerald A. Benjamin, Chief Administrative Officer, Executive Vice President, Director
- Mark E. Mlotek, Chief Strategic Officer, Executive Vice President, Director
- Karen N. Prange, Executive Vice President; Chief Executive Officer of Global Animal Health, Medical and Dental Surgical Group
Who owns Henry Schein stock?
Henry Schein's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (10.19%), FMR LLC (8.72%), BlackRock Inc. (7.18%), State Street Corp (4.56%), Alecta Pensionsforsakring Omsesidigt (3.16%) and Janus Henderson Group PLC (1.85%). Company insiders that own Henry Schein stock include Barry J Alperin, David Mckinley, Donald J Kabat, Gerald A Benjamin, James A Harding, Kurt P Kuehn, Lonnie Shoff, Lorelei Mcglynn, Louis W Sullivan, Mark E Mlotek, Michael Racioppi, Michael S Ettinger, Norman S Matthews, Paul Brons, Paul Rose, Peter M Mccarthy, Philip A Laskawy, Robert Minowitz, Stanley Komaroff, Stanley M Bergman and Steven Paladino. View Institutional Ownership Trends for Henry Schein.
Who sold Henry Schein stock? Who is selling Henry Schein stock?
Henry Schein's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Atlanta Capital Management Co. L L C, JPMorgan Chase & Co., Findlay Park Partners LLP, Bank of New York Mellon Corp, Neuberger Berman Group LLC, State Street Corp and TIAA CREF Investment Management LLC. Company insiders that have sold Henry Schein stock in the last year include Donald J Kabat, Gerald A Benjamin, James A Harding, Lorelei Mcglynn, Mark E Mlotek, Michael Racioppi, Michael S Ettinger, Paul Brons, Paul Rose, Philip A Laskawy and Steven Paladino. View Insider Buying and Selling for Henry Schein.
Who bought Henry Schein stock? Who is buying Henry Schein stock?
Henry Schein's stock was purchased by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Vanguard Group Inc., PGGM Investments, AMI Asset Management Corp, BlackRock Inc., Martingale Asset Management L P, Balyasny Asset Management LLC and AJO LP. View Insider Buying and Selling for Henry Schein.
How do I buy Henry Schein stock?
Shares of Henry Schein can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Henry Schein's stock price today?
One share of Henry Schein stock can currently be purchased for approximately $169.49.
MarketBeat Community Rating for Henry Schein (NASDAQ HSIC)MarketBeat's community ratings are surveys of what our community members think about Henry Schein and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Henry Schein (NASDAQ:HSIC) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 9 Hold Ratings, 6 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.40) |
| Consensus Price Target: | $184.07 (8.60% upside) |
Analysts' Ratings History for Henry Schein (NASDAQ:HSIC)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 8/7/2017 | Northcoast Research | Upgrade | Neutral -> Buy | $218.00 | High |  |
| 7/21/2017 | Jefferies Group LLC | Reiterated Rating | Hold | $177.00 | Low | |
| 7/13/2017 | Credit Suisse Group | Reiterated Rating | Hold | $160.00 -> $160.00 | Low | |
| 7/6/2017 | Stifel Nicolaus | Reiterated Rating | Hold | | Low | |
| 6/12/2017 | Piper Jaffray Companies | Initiated Coverage | Neutral -> Neutral | $200.00 | Low | |
| 5/10/2017 | Barrington Research | Boost Price Target | Outperform -> Outperform | $196.00 -> $198.00 | Low | |
| 4/11/2017 | Craig Hallum | Initiated Coverage | Hold | | Low | |
| 3/15/2017 | Deutsche Bank AG | Initiated Coverage | Hold -> Hold | $174.00 | Low | |
| 2/22/2017 | Leerink Swann | Set Price Target | Hold | $183.00 | N/A | |
| 2/21/2017 | Evercore ISI | Boost Price Target | Hold | $160.00 -> $178.00 | N/A | |
| 1/10/2017 | Gabelli | Upgrade | Hold -> Buy | $208.00 | N/A | |
| 1/3/2017 | Robert W. Baird | Upgrade | Neutral -> Outperform | $164.00 -> $170.00 | N/A | |
| 11/3/2016 | J P Morgan Chase & Co | Reiterated Rating | Hold | $163.00 | N/A | |
| 10/11/2016 | Goldman Sachs Group, Inc. (The) | Upgrade | Neutral -> Buy | $185.00 | N/A | |
| 9/12/2016 | Bank of America Corporation | Initiated Coverage | Buy | $185.00 | N/A | |
| 11/5/2015 | Royal Bank Of Canada | Boost Price Target | Outperform | $165.00 -> $170.00 | N/A | |
(Data available from 8/20/2015 forward)
Earnings History for Henry Schein (NASDAQ:HSIC)Earnings History by Quarter for Henry Schein (NASDAQ HSIC)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 8/8/2017 | Q2 17 | $1.73 | $1.75 | $3.05 billion | $3.06 billion | View | Listen | |
| 5/9/2017 | Q1 17 | $1.65 | $1.76 | $2.83 billion | $2.92 billion | View | Listen | |
| 2/21/2017 | Q416 | $1.85 | $1.88 | $3.08 billion | $3.12 billion | View | Listen | |
| 11/2/2016 | Q316 | $1.65 | $1.68 | $2.88 billion | $2.87 billion | View | N/A | |
| 8/4/2016 | Q216 | $1.63 | $1.64 | $2.85 billion | $2.87 billion | View | N/A | |
| 5/3/2016 | Q116 | $1.39 | $1.41 | $2.66 billion | $2.70 billion | View | Listen | |
| 2/10/2016 | Q415 | $1.65 | $1.67 | $2.82 billion | $2.90 billion | View | Listen | |
| 11/4/2015 | Q315 | $1.47 | $1.55 | $2.70 billion | $2.70 billion | View | Listen | |
| 7/29/2015 | Q215 | $1.46 | $1.46 | $2.68 billion | $2.60 billion | View | Listen | |
| 5/4/2015 | Q1 | $1.27 | $1.28 | $2.54 billion | $25.00 billion | View | Listen | |
| 2/11/2015 | Q414 | $1.51 | $1.56 | $2.72 billion | $2.70 billion | View | Listen | |
| 11/6/2014 | Q314 | $1.31 | $1.34 | $2.55 billion | $2.62 billion | View | Listen | |
| 8/4/2014 | Q214 | $1.33 | $1.35 | $2.56 billion | $2.60 billion | View | Listen | |
| 5/6/2014 | Q1 | $1.13 | $1.18 | $2.43 billion | $2.40 billion | View | Listen | |
| 2/11/2014 | Q413 | $1.39 | $1.43 | $2.53 billion | $2.50 billion | View | Listen | |
| 11/5/2013 | Q313 | $1.21 | $1.22 | $2.37 billion | $2.30 billion | View | Listen | |
| 8/6/2013 | Q2 2013 | $1.23 | $1.23 | $2.39 billion | $2.40 billion | View | Listen | |
| 5/7/2013 | Q1 2013 | $1.07 | $1.06 | $2.25 billion | $2.30 billion | View | Listen | |
| 2/13/2013 | Q4 2012 | $1.21 | $1.26 | $2.40 billion | $2.40 billion | View | Listen | |
| 11/7/2012 | Q312 | $1.07 | $1.08 | $2.24 billion | $2.23 billion | View | N/A | |
| 8/2/2012 | | $1.10 | $1.11 | | | View | N/A | |
| 5/8/2012 | | $0.92 | $0.98 | | | View | N/A | |
| 2/15/2012 | | $1.12 | $1.15 | | | View | N/A | |
| 11/1/2011 | | $1.00 | $0.99 | | | View | N/A | |
| 8/2/2011 | | $1.00 | $1.01 | | | View | N/A | |
| 5/3/2011 | | $0.80 | $0.82 | | | View | N/A | |
| 2/22/2011 | | $0.96 | $1.00 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Henry Schein (NASDAQ:HSIC)2017 EPS Consensus Estimate: $7.17
2018 EPS Consensus Estimate: $8.09
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 5 | $1.60 | $1.67 | $1.64 |
| Q2 2017 | 5 | $1.71 | $1.77 | $1.74 |
| Q3 2017 | 5 | $1.75 | $1.85 | $1.79 |
| Q4 2017 | 5 | $1.98 | $2.02 | $1.99 |
| Q1 2018 | 3 | $1.87 | $2.01 | $1.93 |
| Q2 2018 | 3 | $1.94 | $1.99 | $1.96 |
| Q3 2018 | 3 | $1.98 | $2.03 | $2.01 |
| Q4 2018 | 3 | $2.17 | $2.22 | $2.19 |
(Data provided by Zacks Investment Research)
Dividend History for Henry Schein (NASDAQ:HSIC)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Henry Schein (NASDAQ:HSIC)Insider Ownership Percentage: 1.27%
Institutional Ownership Percentage: 90.60%
Insider Trades by Quarter for Henry Schein (NASDAQ:HSIC)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 5/11/2017 | Gerald A Benjamin | EVP | Sell | 12,578 | $175.10 | $2,202,407.80 | |
| 3/23/2017 | Lorelei Mcglynn | SVP | Sell | 9,300 | $171.76 | $1,597,368.00 | |
| 3/20/2017 | Michael Racioppi | SVP | Sell | 9,969 | $171.69 | $1,711,577.61 | |
| 3/17/2017 | Mark E Mlotek | EVP | Sell | 5,559 | $170.98 | $950,477.82 | |
| 3/8/2017 | James A Harding | SVP | Sell | 10,552 | $171.60 | $1,810,723.20 | |
| 3/8/2017 | Philip A Laskawy | Director | Sell | 1,103 | $171.51 | $189,175.53 | |
| 3/2/2017 | Michael S Ettinger | SVP | Sell | 6,960 | $171.09 | $1,190,786.40 | |
| 2/27/2017 | Donald J Kabat | Director | Sell | 4,334 | $173.62 | $752,469.08 | |
| 2/22/2017 | Paul Rose | SVP | Sell | 6,821 | $173.24 | $1,181,670.04 | |
| 2/22/2017 | Steven Paladino | CFO | Sell | 13,072 | $173.40 | $2,266,684.80 | |
| 12/12/2016 | Kurt P Kuehn | Director | Buy | 1,000 | $151.41 | $151,410.00 | |
| 11/3/2016 | Mark E Mlotek | EVP | Sell | 2,417 | $155.19 | $375,094.23 | |
| 8/29/2016 | Paul Brons | Director | Sell | 3,381 | $164.03 | $554,585.43 | |
| 6/2/2016 | Gerald A Benjamin | EVP | Sell | 9,991 | $175.08 | $1,749,224.28 | |
| 5/16/2016 | James A Harding | SVP | Sell | 10,302 | $172.60 | $1,778,125.20 | |
| 5/12/2016 | Peter M Mccarthy | Insider | Sell | 1,158 | $171.75 | $198,886.50 | |
| 3/15/2016 | Lonnie Shoff | CEO | Sell | 3,028 | $168.29 | $509,582.12 | |
| 3/14/2016 | David Mckinley | Insider | Sell | 3,339 | $167.92 | $560,684.88 | |
| 3/14/2016 | Norman S Matthews | Director | Sell | 5,335 | $167.75 | $894,946.25 | |
| 3/10/2016 | Donald J Kabat | Director | Sell | 1,218 | $168.38 | $205,086.84 | |
| 3/7/2016 | Barry J Alperin | Director | Sell | 1,635 | $167.36 | $273,633.60 | |
| 3/7/2016 | Michael S Ettinger | SVP | Sell | 5,423 | $168.13 | $911,768.99 | |
| 3/4/2016 | Philip A Laskawy | Director | Sell | 1,317 | $166.88 | $219,780.96 | |
| 3/2/2016 | Louis W Sullivan | Director | Sell | 11,735 | $168.59 | $1,978,403.65 | |
| 3/2/2016 | Mark E Mlotek | EVP | Sell | 4,982 | $167.93 | $836,627.26 | |
| 2/26/2016 | Barry J Alperin | Director | Sell | 7,540 | $167.96 | $1,266,418.40 | |
| 2/24/2016 | Robert Minowitz | Insider | Sell | 9,648 | $165.48 | $1,596,551.04 | |
| 2/22/2016 | Michael Racioppi | SVP | Sell | 21,567 | $166.74 | $3,596,081.58 | |
| 2/17/2016 | Stanley Komaroff | Insider | Sell | 8,000 | $163.53 | $1,308,240.00 | |
| 2/16/2016 | Norman S Matthews | Director | Sell | 4,230 | $160.05 | $677,011.50 | |
| 2/12/2016 | Steven Paladino | CFO | Sell | 11,727 | $157.21 | $1,843,601.67 | |
| 2/11/2016 | Donald J. Kabat | Director | Sell | 6,637 | $156.36 | $1,037,761.32 | |
| 12/17/2015 | Michael Racioppi | SVP | Sell | 9,901 | $155.92 | $1,543,763.92 | |
| 12/10/2015 | Stanley M. Bergman | CEO | Sell | 61,800 | $155.45 | $9,606,810.00 | |
| 11/9/2015 | Paul Rose | SVP | Sell | 3,638 | $151.92 | $552,684.96 | |
| 11/5/2015 | Mark E. Mlotek | EVP | Sell | 2,952 | $155.00 | $457,560.00 | |
| 11/5/2015 | Stanley Komaroff | Insider | Sell | 6,297 | $154.89 | $975,342.33 | |
| 9/16/2015 | Philip A Laskawy | Director | Sell | 4,000 | $136.20 | $544,800.00 | |
| 5/6/2015 | Paul Brons | Director | Sell | 3,801 | $136.70 | $519,596.70 | |
| 3/19/2015 | Michael S Ettinger | SVP | Sell | 4,352 | $139.75 | $608,192.00 | |
| 3/18/2015 | James P Breslawski | CEO | Sell | 12,811 | $139.45 | $1,786,493.95 | |
| 3/17/2015 | Leonard A David | SVP | Sell | 3,935 | $140.00 | $550,900.00 | |
| 3/16/2015 | Paul Rose | SVP | Sell | 3,264 | $140.13 | $457,384.32 | |
| 3/13/2015 | Norman S Matthews | Director | Sell | 9,200 | $136.07 | $1,251,844.00 | |
| 3/11/2015 | Philip A Laskawy | Director | Sell | 2,669 | $136.60 | $364,585.40 | |
| 3/10/2015 | Donald J Kabat | Director | Sell | 2,002 | $138.00 | $276,276.00 | |
| 3/5/2015 | Barry J Alperin | Director | Sell | 6,637 | $140.64 | $933,427.68 | |
| 2/24/2015 | Stanley Komaroff | Insider | Sell | 8,000 | $141.69 | $1,133,520.00 | |
| 2/12/2015 | Donald J Kabat | Director | Sell | 5,000 | $142.68 | $713,400.00 | |
| 2/12/2015 | Gerald A Benjamin | EVP | Sell | 22,116 | $142.71 | $3,156,174.36 | |
| 2/12/2015 | Robert Minowitz | Insider | Sell | 11,254 | $142.63 | $1,605,158.02 | |
| 12/18/2014 | Leonard A David | SVP | Sell | 3,557 | $135.34 | $481,404.38 | |
| 12/9/2014 | Stanley M Bergman | CEO | Sell | 69,600 | $135.56 | $9,434,976.00 | |
| 12/8/2014 | Stanley M Bergman | CEO | Sell | 23,485 | $136.34 | $3,201,944.90 | |
| 11/24/2014 | Stanley Komaroff | Insider | Sell | 13,757 | $133.06 | $1,830,506.42 | |
| 11/7/2014 | Lorelei Mcglynn | SVP | Sell | 15,746 | $129.03 | $2,031,706.38 | |
| 11/7/2014 | Mark E Mlotek | EVP | Sell | 6,262 | $128.75 | $806,232.50 | |
| 9/2/2014 | Philip A Laskawy | Director | Sell | 15,438 | $119.40 | $1,843,297.20 | |
| 8/29/2014 | Louis W Sullivan | Director | Sell | 17,262 | $119.99 | $2,071,267.38 | |
| 6/9/2014 | Barry J Alperin | Director | Sell | 7,500 | $120.39 | $902,925.00 | |
| 6/2/2014 | Gerald A Benjamin | EVP | Sell | 12,354 | $119.50 | $1,476,303.00 | |
| 5/28/2014 | Norman S Matthews | Director | Sell | 6,637 | $118.68 | $787,679.16 | |
| 5/19/2014 | Donald Kabat | Director | Sell | 5,000 | $116.30 | $581,500.00 | |
| 5/15/2014 | Paul Brons | Director | Sell | 5,363 | $113.77 | $610,148.51 | |
| 3/19/2014 | Barry Alperin | Director | Sell | 7,500 | $119.18 | $893,850.00 | |
| 3/17/2014 | Lonnie Shoff | CEO | Sell | 3,722 | $119.06 | $443,141.32 | |
| 3/12/2014 | Michael Ettinger | SVP | Sell | 3,537 | $119.20 | $421,610.40 | |
| 3/11/2014 | David Mckinley | Insider | Sell | 2,387 | $119.65 | $285,604.55 | |
| 3/11/2014 | James Breslawski | CEO | Sell | 72,642 | $119.35 | $8,669,822.70 | |
| 3/11/2014 | Paul Rose | SVP | Sell | 3,783 | $119.72 | $452,900.76 | |
| 3/10/2014 | Robert Minowitz | Insider | Sell | 11,553 | $119.98 | $1,386,128.94 | |
| 3/4/2014 | Donald Kabat | Director | Sell | 5,000 | $119.15 | $595,750.00 | |
| 2/28/2014 | Michael Racioppi | SVP | Sell | 18,614 | $118.91 | $2,213,390.74 | |
| 2/26/2014 | Stanley Komaroff | Insider | Sell | 18,000 | $119.36 | $2,148,480.00 | |
| 2/25/2014 | Mark Mlotek | EVP | Sell | 20,333 | $119.16 | $2,422,880.28 | |
| 2/20/2014 | Steven Paladino | CFO | Sell | 28,757 | $117.79 | $3,387,287.03 | |
| 2/12/2014 | Philip Laskawy | Director | Sell | 5,851 | $114.91 | $672,338.41 | |
| 12/19/2013 | Mark Mlotek | EVP | Sell | 22,004 | $111.97 | $2,463,787.88 | |
| 12/19/2013 | Michael Racioppi | SVP | Sell | 29,257 | $111.97 | $3,275,906.29 | |
| 12/17/2013 | Gerald Benjamin | EVP | Sell | 41,664 | $111.66 | $4,652,202.24 | |
| 12/17/2013 | James Breslawski | CEO | Sell | 57,754 | $111.91 | $6,463,250.14 | |
| 12/16/2013 | Steven Paladino | CFO | Sell | 47,652 | $112.31 | $5,351,796.12 | |
| 12/13/2013 | Stanley Bergman | CEO | Sell | 78,000 | $111.90 | $8,728,200.00 | |
| 12/6/2013 | Leonard David | SVP | Sell | 13,968 | $113.14 | $1,580,339.52 | |
| 11/26/2013 | Stanley Komaroff | Insider | Sell | 22,329 | $114.79 | $2,563,145.91 | |
| 8/23/2013 | Philip Laskawy | Director | Sell | 21,637 | $103.17 | $2,232,289.29 | |
| 8/22/2013 | Norman Matthews | Director | Sell | 9,851 | $103.95 | $1,024,011.45 | |
| 8/20/2013 | Louis Sullivan | Director | Sell | 15,000 | $103.91 | $1,558,650.00 | |
| 8/12/2013 | Donald Kabat | Director | Sell | 2,500 | $106.25 | $265,625.00 | |
| 6/18/2013 | Barry J Alperin | Director | Sell | 7,500 | $97.74 | $733,050.00 | |
| 5/8/2013 | James A Harding | CTO | Sell | 12,000 | $92.64 | $1,111,680.00 | |
| 3/8/2013 | Donald J Kabat | Director | Sell | 4,038 | $90.00 | $363,420.00 | |
| 12/4/2012 | Donald J Kabat | Director | Sell | 15,000 | $80.04 | $1,200,600.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Henry Schein (NASDAQ:HSIC)
Latest Headlines for Henry Schein (NASDAQ:HSIC)
| Source: |
|
| Date | Headline |
|---|
 | Cramer’s Exec Cut: The huge millennial influence on moder...
finance.yahoo.com - August 18 at 7:27 PM |
 | Henry Schein (HSIC) Plans 2-for-1 Stock Split - StreetInsider.com
www.streetinsider.com - August 17 at 12:36 AM |
| Henry Schein (HSIC) Plans 2-for-1 Stock Split
www.streetinsider.com - August 16 at 7:36 PM |
 | Henry Schein Board Approves 2-for-1 Stock Split - Quick Facts
www.nasdaq.com - August 16 at 7:36 PM |
| Henry Schein Announces 2-for-1 Stock Split
finance.yahoo.com - August 16 at 7:36 PM |
| CAEK®, Inc. Announces Distribution Agreement with Henry Schein, Inc.
finance.yahoo.com - August 16 at 7:36 PM |
| Henry Schein Launches 2017 Healthy Lifestyles, Healthy Communities Program
finance.yahoo.com - August 11 at 8:04 PM |
| Cramer’s Exec Cut: The new economy driving modern busines...
finance.yahoo.com - August 11 at 8:04 PM |
 | Barrington Research Analysts Boost Earnings Estimates for Henry Schein, Inc. (HSIC)
www.americanbankingnews.com - August 11 at 8:56 AM |
| Henry Schein, Inc. (HSIC) to Post Q4 2017 Earnings of $1.99 Per Share, Barrington Research Forecasts
www.americanbankingnews.com - August 10 at 1:50 PM |
| FY2017 EPS Estimates for Henry Schein, Inc. Decreased by Gabelli (NASDAQ:HSIC)
www.americanbankingnews.com - August 10 at 1:16 PM |
| Northcoast Research Weighs in on Henry Schein, Inc.'s FY2017 Earnings (NASDAQ:HSIC)
www.americanbankingnews.com - August 10 at 9:10 AM |
| Q3 2017 EPS Estimates for Henry Schein, Inc. Reduced by William Blair (NASDAQ:HSIC)
www.americanbankingnews.com - August 10 at 7:06 AM |
 | Henry Schein Now Accepting Applications For The Third Annual Henry Schein Cares Medal - PR Newswire (press release)
www.prnewswire.com - August 9 at 7:49 PM |
| Henry Schein Becomes Oversold (HSIC) - Nasdaq
www.nasdaq.com - August 9 at 7:48 PM |
| See what the IHS Markit Score report has to say about Henry Schein Inc.
finance.yahoo.com - August 9 at 7:48 PM |
| Northcoast Research Weighs in on Henry Schein, Inc.'s Q3 2018 Earnings (NASDAQ:HSIC)
www.americanbankingnews.com - August 9 at 1:30 PM |
 | Henry Schein (HSIC) Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 12:21 AM |
| Henry Schein Reports Record Second Quarter Financial Results
finance.yahoo.com - August 9 at 12:21 AM |
| Henry Schein, Inc. breached its 50 day moving average in a Bullish Manner : HSIC-US : August 8, 2017
finance.yahoo.com - August 9 at 12:21 AM |
| Henry Schein (HSIC) Tops Q2 Earnings and Revenues Estimate
finance.yahoo.com - August 9 at 12:21 AM |
| Edited Transcript of HSIC earnings conference call or presentation 8-Aug-17 2:00pm GMT
finance.yahoo.com - August 9 at 12:21 AM |
| 'Anything to do with digital' is growing rapidly in healt...
finance.yahoo.com - August 9 at 12:21 AM |
| Henry Schein: Cramer's Top Takeaways
finance.yahoo.com - August 9 at 12:21 AM |
| Tuesday Sector Laggards: Materials, Healthcare - Nasdaq
www.nasdaq.com - August 8 at 7:18 PM |
| Henry Schein (HSIC) Tops Q2 EPS by 1c, Beats on Revenues; Offers FY17 EPS Guide Midpoint Below Consensus - StreetInsider.com
www.streetinsider.com - August 8 at 7:18 PM |
| Henry Schein (HSIC) Tops Q2 Earnings and Revenues Estimate - Nasdaq
www.nasdaq.com - August 8 at 7:18 PM |
| Henry Schein beats Street 2Q forecasts
finance.yahoo.com - August 8 at 7:18 PM |
| Cramer Remix: What Disney’s shot at Netflix means for stocks
finance.yahoo.com - August 8 at 7:18 PM |
| Henry Schein, Inc. (HSIC) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS
www.americanbankingnews.com - August 8 at 9:59 AM |
| Henry Schein, Inc. (NASDAQ:HSIC) Updates FY17 Earnings Guidance
www.americanbankingnews.com - August 8 at 9:22 AM |
| Q2 2017 EPS Estimates for Henry Schein, Inc. Raised by Northcoast Research (HSIC)
www.americanbankingnews.com - August 8 at 7:08 AM |
 | Earnings Scheduled For August 8, 2017
feeds.benzinga.com - August 8 at 5:14 AM |
| Henry Schein Now Accepting Applications For The Third Annual Henry Schein Cares Medal
finance.yahoo.com - August 8 at 12:12 AM |
| Med-Product Stocks Aug 8 Earnings Roster: HSIC, AGIO & More - Nasdaq
www.nasdaq.com - August 7 at 7:07 PM |
| $3.05 Billion in Sales Expected for Henry Schein, Inc. (HSIC) This Quarter
www.americanbankingnews.com - August 6 at 7:10 AM |
| Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 8/5/2017 - Nasdaq
www.nasdaq.com - August 5 at 6:31 PM |
| Henry Schein, Inc. (HSIC) Expected to Post Earnings of $1.73 Per Share
www.americanbankingnews.com - August 4 at 6:26 PM |
| Henry Schein, Inc. breached its 50 day moving average in a Bearish Manner : HSIC-US : July 28, 2017
finance.yahoo.com - July 28 at 10:35 PM |
| Henry Schein, Inc. (NASDAQ:HSIC) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - July 28 at 9:17 AM |
| Contrasting Henry Schein (NASDAQ:HSIC) and Patterson Companies (PDCO)
www.americanbankingnews.com - July 27 at 4:25 PM |
| Henry Schein To Webcast Second Quarter 2017 Conference Call On Tuesday, August 8, 2017 At 10:00 A.M. ET
finance.yahoo.com - July 25 at 7:55 PM |
| Can Henry Schein (HSIC) Spring a Surprise in Q2 Earnings?
finance.yahoo.com - July 24 at 11:07 PM |
| ETFs with exposure to Henry Schein, Inc. : July 24, 2017
finance.yahoo.com - July 24 at 11:07 PM |
| Financial Analysis: Henry Schein (NASDAQ:HSIC) versus Owens & Minor (OMI)
www.americanbankingnews.com - July 21 at 10:23 PM |
| Jefferies Group LLC Reaffirms "Hold" Rating for Henry Schein, Inc. (HSIC)
www.americanbankingnews.com - July 21 at 8:56 AM |
| Henry Schein Launches New Medical Website - PR Newswire (press release)
www.prnewswire.com - July 20 at 8:21 PM |
| $3.04 Billion in Sales Expected for Henry Schein, Inc. (NASDAQ:HSIC) This Quarter
www.americanbankingnews.com - July 15 at 8:36 AM |
| ETFs with exposure to Henry Schein, Inc. : July 14, 2017
finance.yahoo.com - July 15 at 12:54 AM |
| Zacks: Analysts Anticipate Henry Schein, Inc. (HSIC) to Post $1.73 EPS
www.americanbankingnews.com - July 13 at 12:27 PM |
Henry Schein (HSIC) Chart for Sunday, August, 20, 2017
